Published: 2021-03-26

Role of sclerotherapy in management of low flow vascular malformations

Manpreet Kaur, Parul Sachdeva, Rajan Syal, Savijot Singh


Background: Low flow vascular malformations are most common in the head and neck region. Only symptomatic malformations require treatment. Sclerotherapy followed by surgery was considered the gold standard treatment but in the head and neck region, it may produce cosmetic and physiological defects. In the present study, multiple injections of sclerotherapy with 3% sodium tetradecyl sulphate was used for the treatment of low flow vascular malformations.

Methods: Twenty cases of low flow vascular malformations of the oral cavity who presented in the outpatient department of ESIC Model Hospital, Ludhiana from 2014-2016 were selected for the study. Only significantly sized (>4 cm) and easily accessible lesions were included. Staged sequential sclerotherapy with 3% STS under strict fluoroscopy control was used as the sole treatment.

Results: A total of 20 patients were taken of which, 25% required three sessions, 65% five to six sessions each and 10% required eight sessions each. All patients showed good results with complete regression and no mucosal ulceration.

Conclusions: Staged sequential sclerotherapy with 3% STS should be the treatment of choice in low flow vascular lesions involving mucosal and cutaneous structures of head and neck region especially anterior two-thirds of tongue, palate, gingiva, buccal mucosa and lips. Surgical removal may affect critical neurovascular structures and cause cosmetic deformity. So the removal is advisable in life-threatening conditions, lesions requiring general anaesthesia and single sitting removal.


Low flow vascular malformations, 3% sodium tetradecyl sulphate, Sclerotherapy

Full Text:



Mullikan JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstruct Surg. 1982;69:412-20.

Monteiro LS, Azevedo A, Cadilhe S, Sousa D, Faria C, Martins M. Laser treatment of vascular anomalies of oral cavity. Rev Port Stomatol Med Dent Maxillofac Surg. 2013;54:171-5.

Widlus DM, Murray RR, White RI, Osterman FA, Schreiber ER, Satre RW, et al. Congenital arteriovenous malformations: tailored embolotherapy. Radiology. 1988;169:511-6.

Manjunath SM, Shetty S, Moon NJ, Sharma B, Metta KK, Gupta N, et al. Arteriovenous malformation of the oral cavity. Case Rep Dent. 2014;353-8.

Low DW. Management of adult facial vascular anomalies. Facial Plast Surg. 2003;19(1):113-30.

Tyagi I, Syal R, Goyal A. Management of low-flow vascular malformations of upper aero digestive system-role of N-butyl cyanoacrylate in peroperative devascularisation. BJOMS. 2006;44:152-6.

Minkow B, Laufer D, Gutman D. Treatment of oral hemangioma with local sclerosing agents. Int J Oral Surg. 1979;8:18-21.

Agarwal S. Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: Study of 20 cases. Indian J Otolaryngol Head Neck Surg. 2012;64(3):205-7.

Saraf S. Role of sodium tetradecyl sulfate in venous malformations. Indian J Dermatol. 2006;5.

Orsel I, Guillame A, Feiss P. Anaphylactic shock caused by fibrin glue. Ann Fr Anesth Reanim. 1997;16(3):292-3.

Tonner PH, Scholz J. Possible lung embolism following embolization of a hemangioma with fibrin glue. Anaesthesist. 1994;43(9):614-67.

Rebeiz E, April MM, Bohigian RK, Shapshay SM. Nd-Yag laser treatment of venous malformations of the head and neck: an update. Otolaryngol Head Neck Surg. 1991;105(5):655-61.

Govrin–Yehudain J, Moscona AR, Calderon N, Hirshowitz B. Treatment of hemangiomas by sclerosing agents : an experimental and clinical study. Ann Plast Surg. 1987;18:465-9.

Gomes AS. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches. Radiology. 1994;190:191-8.

Choi YH, Han MH, O-Ki K, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vase Interv Radiol. 2002;13(5):475-82.

O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR. 1997;169:723-9.